Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company specializing in the development of treatments that aim to slow down the degenerative processes linked to aging and improve functional outcomes of patients suffering from age-related diseases announces its participation in several conferences in the first quarter of 2024.
Biophytis management will be in San Francisco for meetings with potential partners and investors during the 42nd edition of the JP Morgan Healthcare Conference, which will be held January 8-11, 2024.
Moreover ; the company will participate:
– at the Invest Securities Biomed Event which will take place on January 30, 2024 in Paris,
– as well as at the BIO-Europe Spring conference from March 18 to 20, 2024 in Barcelona.